Lonza Group Ltd
O6Z
Company Profile
Business description
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Contact
Muenchensteinerstrasse 38
Basel4002
CHET: +41 613168111
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
19,299
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,244.80 | 11.80 | -0.13% |
CAC 40 | 8,049.21 | 74.36 | 0.93% |
DAX 40 | 24,605.63 | 219.85 | 0.90% |
Dow JONES (US) | 46,665.64 | 62.66 | 0.13% |
FTSE 100 | 9,542.33 | 58.75 | 0.62% |
HKSE | 26,829.46 | 128.31 | -0.48% |
NASDAQ | 22,941.24 | 152.88 | 0.67% |
Nikkei 225 | 47,734.99 | 215.89 | -0.45% |
NZX 50 Index | 13,568.48 | 37.19 | 0.27% |
S&P 500 | 6,740.97 | 26.38 | 0.39% |
S&P/ASX 200 | 8,947.60 | 10.80 | -0.12% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |